Skip to main content
NEXTURNBIOSCIENCE Co., LTD logo

NEXTURNBIOSCIENCE Co., LTD — Investor Relations & Filings

Ticker · 089140 ISIN · KR7089140008 KO Professional, scientific and technical activities
Filings indexed 486 across all filing types
Latest filing 2022-05-20 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 089140

About NEXTURNBIOSCIENCE Co., LTD

http://www.nexturn.co.kr

NEXTURNBIOSCIENCE Co., LTD. is a specialized manufacturer of Computer Numerical Control (CNC) automatic lathes, with a focus on Swiss-type models. The company develops and produces a range of machines, including both guide bush and non-guide bush types, utilizing proprietary technology. In addition to its core machinery business, NEXTURNBIOSCIENCE leverages its expertise in ultra-precision manufacturing to produce essential functional components. These high-quality parts serve critical applications across diverse sectors, including information technology (IT), construction equipment, and the medical industry, reflecting the company's expanding business scope.

Recent filings

Filing Released Lang Actions
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Nexturn Bio) regarding the adjustment of the conversion price of convertible bonds due to a decline in market price. This type of disclosure, which details changes to capital structure instruments like convertible bonds, falls under the category of capital and financing updates.
2022-05-20 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price of convertible bonds due to a decline in market price. This type of disclosure, which affects the company's capital structure and potential share dilution, is classified under 'Capital/Financing Update' (CAP) as it pertains to financing instruments and their terms.
2022-05-19 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Nexturn Bioscience, covering the period from 2022.01.01 to 2022.03.31. It contains detailed financial and operational information, including company overview, business descriptions, production capacity, and financial data tables. This fits the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (pledges) of a major shareholder (Studio Santa Claus Entertainment) in the issuer (Nexturn Bioscience). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-05-16 Korean
타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from Nexturn Bio regarding the acquisition of shares in another company (Roll Korea Co., Ltd.). It details the acquisition price, number of shares, purpose of acquisition, and financial status of the target company. This type of disclosure regarding M&A activity or significant asset acquisition is classified under 'M&A Activity' (TAR) in the provided schema.
2022-05-13 Korean
[기재정정]소액공모공시서류(지분증권)
Share Issue/Capital Change Classification · 100% confidence The document is a '소액공모공시서류' (Small-scale Public Offering Disclosure Document) filed by Nexturn Bioscience. It details a third-party allocation capital increase (유상증자) and includes specific sections on the offering process, share issuance, and investment risks. This type of filing is a regulatory requirement for small-scale public offerings in South Korea, which falls under the category of 'Regulatory Filings' (RNS) as it is a specific type of corporate disclosure that does not fit into the other specialized categories like 10-K or Earnings Release.
2022-05-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.